Kelly Elleson
Melanoma Surgeon, Breast Surgeon
MD, FACS
Languages spoken
English
Overview
Dr. Kelly Elleson is a fellowship-trained breast surgeon, certified by both the American Board of Surgery and the Society of Surgical Oncology. She completed a breast surgical oncology fellowship at Moffitt Cancer Center in Tampa, Florida, as well as a research fellowship in surgical oncology, with a focus on melanoma and cutaneous malignancies.
Dr. Elleson specializes in the care of those with all types of breast disease — from benign cysts to complex and metastatic breast cancer. In addition to performing advanced breast and melanoma surgeries, including mastectomies, lumpectomies, and sentinel lymph node biopsies, she has particular expertise in surgical techniques designed to prevent lymphedema.
A Fort Myers native, Dr. Elleson is deeply committed to providing patient-centered, multidisciplinary care to her community. She sees patients throughout Southwest Florida and was recently inducted as a Fellow of the American College of Surgeons (FACS), a prestigious designation that reflects her dedication to the highest standards of surgical excellence, ethical practice, and compassionate care.
Universities
- M.D. Vanderbilt University, Nashville, TN
- M.S. Georgetown University, Washington, D.C.
- B.S. University of Florida, Gainesville, FL
Fellowships
- Breast Surgical Oncology Fellow, H. Lee Moffitt Cancer Center, director: Susan Hoover, MD
- Cutaneous Surgical Oncology Research Fellow, H. Lee Moffitt Cancer Center, director: Jonathan Zager, MD
Residency
- General Surgery Resident, Northwestern University
- Englander K, Chintapally N, Gallagher J, Elleson K, Sun W, Whiting J, Laronga C, Lee MC. Factors Influencing Lymph Node Positivity in HER2/neu+ Breast Cancer Patients. Curr Oncol. 2023 Feb 27;30(3):2825-2833. doi: 10.3390/curroncol30030215. PMID: 36975428; PMCID: PMC10047436.
- Beekman KE, Parker LM, DePalo DK, Elleson KM, Sarnaik AA, Tsai KY, Withycombe BM, Zager JS. Four cases of disseminated herpes simplex virus following talimogene laherparepvec injections for unresectable metastatic melanoma. JAAD Case Rep. 2023 Jan 27;33:56-58. doi: 10.1016/j.jdcr.2022.12.023. PMID: 36860805; PMCID: PMC9969237.
- DePalo DK, Elleson KM, Carr MJ, Spiess PE, Zager JS. Genitourinary melanoma: An overview for the clinician. Asian J Urol. 2022 Oct;9(4):407-422. doi: 10.1016/j.ajur.2022.01.003. Epub 2022 Jun 2. PMID: 36381597; PMCID: PMC9643129.
- Gautam N, Elleson KM, Ramamoorthi G, Czerniecki BJ. Current State of Cell Therapies for Breast Cancer. Cancer J. 2022 Jul-Aug 01;28(4):301-309. doi: 10.1097/PPO.0000000000000607. PMID: 35880940; PMCID: PMC9336570.
- Elleson KM, DePalo DK, Zager JS. An update on local and systemic therapies for nonmelanoma skin cancer. Expert Rev Anticancer Ther. 2022 May;22(5):479-489. doi: 10.1080/14737140.2022.2065987. Epub 2022 Apr 20. PMID: 35412413.